Johnson & Johnson (NYSE:JNJ) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental Biologics License Application (sBLA) for subcutaneous ...
The Hearty Soul on MSN
Popular blood pressure drug linked to higher risk of low potassium and kidney problems
Chlorthalidone raises hypokalemia risk in nearly 9% of patients, outpacing hydrochlorothiazide. The post Popular Blood ...
Spread the love“`html The conversation around Artificial Intelligence in our K-12 classrooms has been building for a while ...
Spread the love“`html Alright, let’s talk about something that’s quietly, or maybe not so quietly, transforming the very ...
Oakmark Global Fund (Investor Class) underperformed the benchmark, the MSCI World Index, for the quarter, but outperformed ...
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the second quarter ended June 30, 2026.
Net revenue for the second quarter increased 14.0% year over year to $105.2 million and increased 12.2% year over year on a ...
Dosing underway in Phase 2a multidose portion of the INLIGHTTM trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with obesity (BMI: 35-50 ...
Second Quarter Results Total revenues of $38.4 million, a 5% year-over-year improvementNet loss of $(4.6) million and loss per share of $(1.71), ...
Adjusted EBITDA is used as a performance measure derived from operating results, excluding significant items, as part of the calculation of Adjusted net debt to adjusted EBITDA. Detailed quarterly ...
Patrick Industries, Inc. ("Patrick" or the "Company"), a leading component solutions provider for the Outdoor Enthusiast and Housing markets, today reported financial results for the second quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results